Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers
NCT04803708
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Foot Ulcer
Pseudomonas Aeruginosa Infection
Staphylococcus Aureus Infection
Acinetobacter Infection
Interventions
BIOLOGICAL:
TP-102
Sponsor
Technophage, SA
Collaborators
[object Object]